ATE472533T1 - N-(4-aryloxypiperidin-1-ylalkyl)zimtsäureamide als ccr3-rezeptorantagonisten - Google Patents
N-(4-aryloxypiperidin-1-ylalkyl)zimtsäureamide als ccr3-rezeptorantagonistenInfo
- Publication number
- ATE472533T1 ATE472533T1 AT01976285T AT01976285T ATE472533T1 AT E472533 T1 ATE472533 T1 AT E472533T1 AT 01976285 T AT01976285 T AT 01976285T AT 01976285 T AT01976285 T AT 01976285T AT E472533 T1 ATE472533 T1 AT E472533T1
- Authority
- AT
- Austria
- Prior art keywords
- sub
- sup
- alkyl
- img
- character
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Neurology (AREA)
- Dermatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Biomedical Technology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0024675A GB0024675D0 (en) | 2000-10-09 | 2000-10-09 | Organic compounds |
| GB0120549A GB0120549D0 (en) | 2001-08-23 | 2001-08-23 | Organic compounds |
| PCT/EP2001/011627 WO2002030898A1 (en) | 2000-10-09 | 2001-10-08 | N-(4-aryloxypiperidin-1-ylalkyl) cinnamic amides as ccr33 receptor antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE472533T1 true ATE472533T1 (de) | 2010-07-15 |
Family
ID=26245127
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01976285T ATE472533T1 (de) | 2000-10-09 | 2001-10-08 | N-(4-aryloxypiperidin-1-ylalkyl)zimtsäureamide als ccr3-rezeptorantagonisten |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US7034042B2 (enExample) |
| EP (1) | EP1330436B1 (enExample) |
| JP (1) | JP4199539B2 (enExample) |
| CN (1) | CN1209351C (enExample) |
| AT (1) | ATE472533T1 (enExample) |
| AU (1) | AU2001295601A1 (enExample) |
| BR (1) | BR0114485A (enExample) |
| CA (1) | CA2423296C (enExample) |
| DE (1) | DE60142484D1 (enExample) |
| ES (1) | ES2348290T3 (enExample) |
| PT (1) | PT1330436E (enExample) |
| WO (1) | WO2002030898A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0117387D0 (en) * | 2001-07-17 | 2001-09-05 | Novartis Ag | Organic compounds |
| US7524841B2 (en) * | 2002-04-25 | 2009-04-28 | Teijin Limited | 4,4-disubstituted piperidine derivatives having CCR3 antagonism |
| ZA200803939B (en) * | 2005-11-24 | 2009-10-28 | Eisai R&D Man Co Ltd | Morpholine type cinnamide compound |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4673684A (en) | 1984-04-04 | 1987-06-16 | Terumo Corporation | Amide derivatives and 5-lipoxygenase inhibitors containing the same as an active ingredient |
| JPH0660160B2 (ja) | 1985-12-13 | 1994-08-10 | テルモ株式会社 | アミド誘導体およびこれを含有する抗アレルギ−剤 |
| JPS63139124A (ja) | 1986-12-01 | 1988-06-10 | Terumo Corp | 腎炎治療剤 |
| JPS63179869A (ja) | 1987-01-20 | 1988-07-23 | Dainippon Pharmaceut Co Ltd | ピペリジン誘導体 |
| DE19756235A1 (de) | 1997-12-17 | 1999-07-01 | Klinge Co Chem Pharm Fab | Neue piperidinylsubstituierte Pyridylalkan- alken- und -alkincarbonsäureamide |
| EE200100502A (et) | 1999-03-26 | 2002-12-16 | Astrazeneca Ab | Ühendid |
| TWI227231B (en) * | 2000-07-12 | 2005-02-01 | Novartis Ag | 4-benzoyl-piperidine derivatives for treating conditions mediated by CCR-3 |
-
2001
- 2001-10-08 US US10/398,533 patent/US7034042B2/en not_active Expired - Fee Related
- 2001-10-08 EP EP01976285A patent/EP1330436B1/en not_active Expired - Lifetime
- 2001-10-08 AT AT01976285T patent/ATE472533T1/de active
- 2001-10-08 CA CA002423296A patent/CA2423296C/en not_active Expired - Fee Related
- 2001-10-08 PT PT01976285T patent/PT1330436E/pt unknown
- 2001-10-08 AU AU2001295601A patent/AU2001295601A1/en not_active Abandoned
- 2001-10-08 WO PCT/EP2001/011627 patent/WO2002030898A1/en not_active Ceased
- 2001-10-08 CN CNB018171028A patent/CN1209351C/zh not_active Expired - Fee Related
- 2001-10-08 BR BR0114485-5A patent/BR0114485A/pt not_active IP Right Cessation
- 2001-10-08 JP JP2002534284A patent/JP4199539B2/ja not_active Expired - Fee Related
- 2001-10-08 DE DE60142484T patent/DE60142484D1/de not_active Expired - Lifetime
- 2001-10-08 ES ES01976285T patent/ES2348290T3/es not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| PT1330436E (pt) | 2010-10-11 |
| CN1209351C (zh) | 2005-07-06 |
| AU2001295601A1 (en) | 2002-04-22 |
| BR0114485A (pt) | 2003-11-18 |
| US7034042B2 (en) | 2006-04-25 |
| WO2002030898A1 (en) | 2002-04-18 |
| ES2348290T3 (es) | 2010-12-02 |
| DE60142484D1 (de) | 2010-08-12 |
| EP1330436B1 (en) | 2010-06-30 |
| JP4199539B2 (ja) | 2008-12-17 |
| US20040087621A1 (en) | 2004-05-06 |
| CA2423296A1 (en) | 2002-04-18 |
| EP1330436A1 (en) | 2003-07-30 |
| CN1468222A (zh) | 2004-01-14 |
| JP2004511467A (ja) | 2004-04-15 |
| CA2423296C (en) | 2009-12-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR035548A1 (es) | Compuestos organicos | |
| CY1106679T1 (el) | Αζαδικυκλικες ετεροκυκλικες ενωσεις ως τροποποιητες κανναβινοειδους υποδοχεα | |
| HUP9802859A2 (hu) | Acil-amino-szalicilsav-amid-származékok és alkalmazásuk peszticidként | |
| MY126139A (en) | Piperidine compounds for use as ccr-3 inhibitors | |
| ECSP034611A (es) | Aminotiazoles y su uso como antagonistas del receptor de adenosina | |
| NO20075312L (no) | N-(N-sulfonylaminometyl)cyklopropankarboksamidderivater nyttige ved smertebehandling | |
| DK0944617T3 (da) | Krystaller af benzimidazolderivater og deres fremstilling | |
| CY1116183T1 (el) | Πιπεραζινοδιονες ως ανταγωνιστες υποδοχεα οξυτοκινης | |
| MY119238A (en) | 8-quinolinzanthine and 8-isoquinolinxanthine derivatives as pde 5 inhibitors | |
| ECSP045369A (es) | Derivados de n-[fenil(piperidin-2-il)metil]benzamida, su preparacion y su aplicacion en terapeutica | |
| ATE29255T1 (de) | Succinimid-derivate und deren herstellung. | |
| DE60316672D1 (de) | Polycyclische verbindungen als potenten alpha2-adrenoceptor antagonisten | |
| WO2003082861A3 (en) | Morpholinyl-urea derivatives for use of the treatment of inflammatory diseases | |
| DE602005027213D1 (de) | Neue imidazolidinderivate | |
| BRPI0506927A (pt) | compostos orgánicos | |
| DE60327922D1 (de) | Harnstoff-linker verbindungen und ihre verwendung als ppar regulatoren | |
| CR7249A (es) | Derivados de diamina, proceso para producir los derivados de diamina, y funguicidas que contienen los derivados de diamina como ingrediente activo | |
| PE20070212A1 (es) | Heterociclos de 1,4-dihidropiridina-condensados, procesos para preparar los mismos, uso y composiciones que los contienen | |
| FR2847899B1 (fr) | Derives d'indole-3-carboxamide, leur preparation et leur application en therapeutique | |
| AR065270A1 (es) | Derivados de imidazolina, composiciones insecticidas, acaricidas, molusquicidas y nematicidas que los comprenden y usos de los mismos en el control de dichas plagas. | |
| ATE472533T1 (de) | N-(4-aryloxypiperidin-1-ylalkyl)zimtsäureamide als ccr3-rezeptorantagonisten | |
| NO20016267L (no) | Nye kvatern¶re ammoniumforbindelser, en fremgangsmåte for fremstilling av dem og den farmasöytiske anvendelse derav | |
| AR045669A1 (es) | Derivados de amida que contienen silicio, con actividad microbicida | |
| HUP9701325A1 (hu) | Új 2,3-benzodiazepin-származékok | |
| DE60026161D1 (de) | Amidin-derivate, ihre herstellung und verwendung als medikamenten |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1330436 Country of ref document: EP |